NCT07058922

Brief Summary

Arterial hypertension is a major public health issue and is considered to be a new epidemic due to its high mortality and morbidity rates. Elevated blood pressure levels increase the risk of coronary artery disease, heart failure, stroke, chronic kidney disease and death. Dietary nitrate supplementation in the form of beetroot powder extract may offer a more accessible way to increase systemic nitric oxide availability and consequently promote vasodilation in these patients. However, studies are needed to assess its benefits in patients with hypertension.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P75+ for early_phase_1

Timeline
6mo left

Started Jun 2024

Typical duration for early_phase_1

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress77%
Jun 2024Dec 2026

Study Start

First participant enrolled

June 1, 2024

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

July 1, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 10, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

July 23, 2025

Status Verified

July 1, 2025

Enrollment Period

2.5 years

First QC Date

July 1, 2025

Last Update Submit

July 18, 2025

Conditions

Keywords

arterial hypertensionsystemic microcirculationbeetroot extract

Outcome Measures

Primary Outcomes (1)

  • Blood pressure

    ABPM - measurement of systolic, diastolic and mean arterial pressure.

    60 days of tratment

Secondary Outcomes (1)

  • Systemic microvascular reactivity

    60 days treatment

Study Arms (2)

beetroot powder extract supplement

EXPERIMENTAL

A powdered beetroot extract supplement containing 400 mg of nitrate per dose will be used in the supplement group, administered orally at a daily amount of 10 g.

Diagnostic Test: evaluation of systemic microvascular reactivityDiagnostic Test: ABPMDietary Supplement: beetroot supplement

placebo control

PLACEBO COMPARATOR

An isocaloric, colored, and flavored supplement composed of maltodextrin will be orally administered.

Diagnostic Test: evaluation of systemic microvascular reactivityDiagnostic Test: ABPM

Interventions

Evaluation of systemic microvascular reactivity using laser speckle contrast imaging.

beetroot powder extract supplementplacebo control
ABPMDIAGNOSTIC_TEST

Ambulatory blood pressure measuring: systolic, diastolic and mean arterial pressures

beetroot powder extract supplementplacebo control
beetroot supplementDIETARY_SUPPLEMENT

A powdered beetroot extract supplement containing 400 mg of nitrate per dose will be used in the supplement group, administered orally at a daily amount of 10 g.

beetroot powder extract supplement

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Resistant hypertensive patients, with a diagnosis documented in medical records, without any change in medication or increase in dosage in the past 30 days.

You may not qualify if:

  • Patients will be excluded from the study if they have: neoplasms, heart failure, are using medications containing nitrate in their formulation, or have undergone renal denervation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institute of Cardiology

Rio de Janeiro, Rio de Janeiro, 20397-230, Brazil

Location

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Nutritional supplement containing a powdered beetroot extract - 400 mg of nitrate per dose will be used in the supplement group, administered orally at a daily amount of 10 g.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
senior researcher

Study Record Dates

First Submitted

July 1, 2025

First Posted

July 10, 2025

Study Start

June 1, 2024

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

July 23, 2025

Record last verified: 2025-07

Locations